@redhotpepper: i read it somewhere and I could always be wrong as I am not in the midst of the market in Malaysia and I don't speak Malay. Seems you're still sour when I was right about the "resistance" comment and the fact the share price shot from 1.86 a month ago to 2.05 today. If you want to be grumpy, by all means be grumpy, but with someone else.
@Jonathan Keung, it ticks so many boxes: 1- A bank 2- Islamic 3- Backed by a strong institution ( Malaysia Army I think) 4- Profitable 6- Potential for takeover with a strong book value (more than double the last time I checked). Nothing to dislike. Correct me if I am wrong. Add points as you see fit
They are guessing special dividend at 15sens , as AFFIN need the capital to grow the Loan segment. Collect the golden eggs , not killing the golden goose .
We maintain our GGM-derived PBV TP of RM2.45 (COE: 11.3%, TG: 3.0%, ROE: 7%) and OP call. Post a meeting with the group at its recently launched TRX Headquarters, we are convinced of AFFIN achieving its ambitious FY22 targets with some resiliency against economic headwinds. Disposal of its business units will help to fuel its key banking division’s endeavours. There is no adjustment to our TP based on ESG of which it is given a 3-star rating as appraised by us. AFFIN is one of our 3QCY22 sector top picks.
Key takeaways are as follows:
- Disposal of AHAM to boost organic growth in banking division. The sale of AHAM will unlock RM1.54b in cash, likely to be sealed by the end of July 2022. This will elevate CET-1 levels to 16% (from 13.7%). The group opines that injecting said capital could stimulate the group’s banking units and add NII of RM190m (+11% to current estimates) in two years. Meanwhile, due to non-compete agreement, AFFIN will abstain from any new asset management ventures for 18 months post sale.
- Capital considerations first and then dividends. The group opines that it will ensure working capital targets are sufficiently fulfilled before it considers the quantum of special dividends that may be paid. Of the RM1.54b proceeds, if we were to estimate a payout of 25% to shareholders, this could translate to c.18.0 sen in special dividends or 9% yield while still keeping CET-1 level at c.15.8%.
- AXA to also close in 3QFY22. The disposal of stakes in AXA Affin Life and General to the JV with MPI Generali (estimated to be completed end-Aug 2022) will provide additional RM155m cash while still being earnings accretive as an associate. That said, operational integration of this JV is expected to only materialise by 1QFY23. Post merger, the combined gross written premium is expected to stand at c.RM2.0b, behind market leader Allianz’s RM2.35b book. There could be a two-pronged growth enjoyed with Generali’s non-cannibalistic product offerings on top of operational synergies from the merged entity, uplifting the segment’s overall contribution to beat its historical 5% of group earnings, going forward.
- Unhindered by recent macro developments. The group remains confident that its 12% loans growth (industry highest) target for FY22 is attainable. Although recent OPR hikes pose headwinds to affordability, strength of the SMEs is expected to remain solid as the local economic growth remains on track. This will be balanced by the launch of its mobile banking app in 4QFY22 to keep CASA and funding costs sticky. Meanwhile, NOII will be cushioned by encouraging reception of its wealth products amidst sluggish investment and trading performance.
Post update, we leave our FY22E/FY23E assumptions unchanged.
Maintain OUTPERFORM and TP of RM2.45. Our TP is based on a GGM-derived PBV of 0.48x (COE: 11.3%, TG: 3.0%, ROE: 7%) on our FY23E BVPS of RM5.07. We believe AFFIN’s monetisation of its business units (AHAM and AXA Affin) could progressively refine AFFIN’s identity as a more comparable traditional bank akin to its listed peers, which may at times fetch a higher valuation for the group. At the meantime, its dividend yield prospects of 5-6% (excluding possible special dividends) could incentivise investors to overlook its low ROE levels which should gradually be enhanced with its growth plans.
Risks to our call include: (i) higher-than-expected margin squeeze, (ii) lower-than-expected loans growth, (iii) worse-than-expected deterioration in asset quality, (iv) slowdown in capital market activities, (v) unfavourable currency fluctuations, and (vi) changes to OPR.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Markv572421
3,374 posts
Posted by Markv572421 > 2022-06-10 09:05 |
Post removed.Why?